Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This gene is annotated as a pseudogene within the UDP-glucuronosyltransferase 2 family and named "polypeptide A3 pseudogene." Pseudogenes are segments of DNA that resemble functional genes but typically do not encode functional proteins. There is no evidence that ENSG00000251691 expresses an active enzyme, and thus it is not involved in drug metabolism, detoxification, or other biological functions associated with active UGT enzymes[5][7]. It is not considered a therapeutic or pharmacological target. The canonical active family members (e.g., UGT2A3, UGT2A1, UGT2A2) participate in metabolism and detoxification, but pseudogenes such as this one are by definition non-functional[3][4][5]. If you are seeking a molecular target for drug metabolism or pharmacogenomics, UGT2A3 (not the pseudogene) or other functional UGTs would be relevant[3][4][6]. Key conventions followed: - Full standardized name provided - Pseudogene status clarified - Abbreviation not attached due to lack of canonical form - Aliases returned only if widely used - Families, functions, roles, interacting drugs, mechanisms, and biomarkers marked null due to pseudogene, not protein-coding status
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on UDP glucuronosyltransferase 2 family, polypeptide A3 pseudogene.